These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 826935)

  • 1. Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives.
    Costall B; Naylor RJ; Pinder RM
    Psychopharmacology (Berl); 1976 Jul; 48(2):225-31. PubMed ID: 826935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain.
    Jackson DM; Andén NE; Dahlström A
    Psychopharmacologia; 1975 Dec; 45(2):139-49. PubMed ID: 1215445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting.
    Costall B; Naylor RJ; Cannon JG; Lee T
    Eur J Pharmacol; 1977 Feb; 41(3):307-19. PubMed ID: 556988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
    Watling KJ; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens.
    Pycock CJ; Horton RW
    J Neural Transm; 1979; 45(1):17-33. PubMed ID: 112217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens.
    Costall B; Naylor RJ; Pinder RM
    Eur J Pharmacol; 1976 Sep; 39(1):153-60. PubMed ID: 134899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine in the rat nucleus accumbens: effects on the synthesis of 5-hydroxytryptamine and noradrenaline, the motor activity and the body temperature.
    Grabowska M; Andén NE
    J Neural Transm; 1976; 38(1):1-8. PubMed ID: 1262861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: possible dependence on dopaminergic mechanisms.
    Donzanti BA; Uretsky NJ
    Neuropharmacology; 1983 Aug; 22(8):971-81. PubMed ID: 6137783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central action of beta-phenylethylamine derivatives. (4) Effects on spontaneous motor activity and body temperature of beta phenylethyamine derivatives injected into the brain in reserpine pretreated mice].
    Sakurada S; Shoji T; Kisara K
    Nihon Yakurigaku Zasshi; 1975 Oct; 71(7):683-90. PubMed ID: 765240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.
    O'Neill KA; Carelli RM; Jarvis MF; Liebman JM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):739-45. PubMed ID: 2560212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens.
    Hamilton MH; De Belleroche JS; Gardiner IM; Herberg LJ
    Pharmacol Biochem Behav; 1986 Nov; 25(5):943-8. PubMed ID: 2878446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
    Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
    Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi.
    Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1975 Nov; 27(11):875-7. PubMed ID: 1503
    [No Abstract]   [Full Text] [Related]  

  • 17. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.
    Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1984; 82(3):174-80. PubMed ID: 6144126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1975 May; 32(1):87-92. PubMed ID: 1171020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate induced-hypermotility response after bilateral injection into the nucleus accumbens of the rat. Possible mediation through dopaminergic mechanisms.
    Stephens RL; Uretsky NJ
    Neuropharmacology; 1986 Aug; 25(8):887-96. PubMed ID: 3022181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.